Cancer genetic alterations and risk of venous thromboembolism
During the 11th ICTHIC, Simon Mantha talked about the relationship between genetic cancer alteration and the risk of...
Basic Mechanisms
PODCAST. Drug-drug interactions: Implications for anticoagulation use in patients with cancer
Cancer patients have an increased risk of VTE by at least 12-fold, and cancer therapies increase the risk of VTE by a...
Diagnosis, screening, and prevention of cancer-associated thrombosis
The tight association between malignancies and hypercoagulation was highlighted almost a century ago by the...
The role of neutrophils in cancer and thrombosis. Waiting for ICTHIC 2022
The role of neutrophils in innate immunity is well known, but only recently they have been linked to other phenomena...
D-dimer and its role in venous thromboembolism
D-dimer is a marker of coagulation activation and thrombotic activity. The analysis of D-dimer levels is used to...
Platelet-educated cancer cells and tumor-educated platelets: an egg-and-chicken debate
Platelets are versatile cells with known functions in hemostasis, thrombosis, inflammation, and several pathological...
Genetic and epigenetic factors in CAT
Cancer and thrombosis are associated with a vicious cycle in which cancer can amplify the risk of thrombosis, and...
Late-breaking research: relationship between PAI-1 cancer cell expression and thrombosis in pancreatic cancer
The urokinase plasminogen activator system is a serine protease family, including urokinase-type plasminogen activator...
Interplay between the hematologic system and solid tumor progression
A relationship between coagulation and cancer has been known since the 19th century, when Armand Trousseau first...
miRNA and its role in cancer-associated thrombosis
Cancer-associated thrombosis (CAT) is one of the leading causes of non-cancer-related deaths in patients with cancer...